Kuros Biosciences Ltd. | Mutual Funds
Mutual Funds that own Kuros Biosciences Ltd.
Swiss Helvetia Fund
116,450
1.41%
0
0.28%
12/31/2017
Falcon Fund SICAV - Small & Mid Cap Equity Fund
47,415
0.57%
43,751
1.01%
12/31/2017
40,072
0.49%
40,072
0.38%
12/31/2017
22,000
0.27%
22,000
1.62%
12/31/2017
CSIF Switzerland Total Market Index
21,574
0.26%
865
0%
05/31/2018
UBS (CH) Institutional Fund - Equities Switzerland Passive All
11,250
0.14%
0
0%
12/29/2017
Dynatrend Fund
10,133
0.12%
0
0.41%
07/31/2018
10,000
0.12%
0
0%
12/29/2017
CSIF Switzerland Small & Mid Cap Index
7,764
0.09%
0
0.01%
05/31/2018
ZKB - CIF Swiss Total Market Index
6,557
0.08%
0
0%
07/31/2018
| Address |
Wagistrasse 25
Schlieren Zurich 8952
Switzerland
|
|
Employees
|
- |
| Website |
http://www.kurosbiosciences.com |
| Updated |
07/08/2019 |
| Kuros Biosciences Ltd. engages in the development of products for tissue repair and regeneration. Its products include sealants for tissue restore and orthobiologics for bone healing. The company was founded by Didier Cowling and Jason Schense in 2000 and is headquartered in Schlieren, Switzerland. |
